カテゴリー： 世界, 医療/バイオ, LP Information

世界のアログリプチン安息香酸塩錠市場予測 2023年-2029年

【英語タイトル】Global Alogliptin Benzoate Tablet Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC05240）・商品コード：LP23DC05240
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアログリプチン安息香酸塩錠市場」は、過去の販売実績から2022年の世界のアログリプチン安息香酸塩錠の総販売量を検討し、2023年から2029年の予測されるアログリプチン安息香酸塩錠の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアログリプチン安息香酸塩錠の市場規模を掲載し、XXX百万米ドル規模の世界のアログリプチン安息香酸塩錠市場の詳細な分析を提供します。本インサイトレポートは、世界のアログリプチン安息香酸塩錠業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアログリプチン安息香酸塩錠市場における各社の独自のポジションをより深く理解するために、アログリプチン安息香酸塩錠製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアログリプチン安息香酸塩錠市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アログリプチン安息香酸塩錠の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アログリプチン安息香酸塩錠の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アログリプチン安息香酸塩錠のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アログリプチン安息香酸塩錠の世界主要メーカーとしては、Takeda Pharmaceutical、 Perrigo、 Navana Pharmaceuticals、 China National Medicines Guorui Pharmaceutical、 Reyoung Pharmaceutical、 Yichang HEC ChangJiang Pharmaceutical、 Chongqing Kerui Nanhai Pharmaceutical、 Yabao Pharmaceutical、 Zhejiang Huabett Pharmaceutical、 Sunshine Lake Pharma、 Jiangsu Deyuan Pharmaceutical、 Qianjin Xiangjiang Pharmageuical、 CSPC Ouyi Pharmaceutical、 Shenzhen Haibin Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアログリプチン安息香酸塩錠市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアログリプチン安息香酸塩錠市場をセグメンテーションし、種類別 (6.25mg/錠、12.5mg/錠、25mg/錠)、用途別 (病院、診療所、薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：6.25mg/錠、12.5mg/錠、25mg/錠

・用途別区分：病院、診療所、薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアログリプチン安息香酸塩錠市場の10年間の市場状況・展望は？
・世界および地域別に見たアログリプチン安息香酸塩錠市場成長の要因は何か？
・アログリプチン安息香酸塩錠の市場機会はエンドマーケットの規模によってどのように変化するのか？
・アログリプチン安息香酸塩錠のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アログリプチン安息香酸塩錠の年間販売量2018-2029、地域別現状・将来分析
・アログリプチン安息香酸塩錠の種類別セグメント：6.25mg/錠、12.5mg/錠、25mg/錠
・アログリプチン安息香酸塩錠の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アログリプチン安息香酸塩錠の用途別セグメント：病院、診療所、薬局
・アログリプチン安息香酸塩錠の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアログリプチン安息香酸塩錠市場
・企業別のグローバルアログリプチン安息香酸塩錠市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアログリプチン安息香酸塩錠の年間売上：2018-2023年の売上、市場シェア
・企業別のアログリプチン安息香酸塩錠販売価格
・主要企業のアログリプチン安息香酸塩錠生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アログリプチン安息香酸塩錠の地域別レビュー
・地域別のアログリプチン安息香酸塩錠市場規模2018-2023：年間販売量、売上
・主要国別のアログリプチン安息香酸塩錠市場規模2018-2023：年間販売量、売上
・南北アメリカのアログリプチン安息香酸塩錠販売の成長
・アジア太平洋のアログリプチン安息香酸塩錠販売の成長
・ヨーロッパのアログリプチン安息香酸塩錠販売の成長
・中東・アフリカのアログリプチン安息香酸塩錠販売の成長

南北アメリカ市場
・南北アメリカの国別のアログリプチン安息香酸塩錠販売量、売上（2018-2023）
・南北アメリカのアログリプチン安息香酸塩錠の種類別販売量
・南北アメリカのアログリプチン安息香酸塩錠の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアログリプチン安息香酸塩錠販売量、売上（2018-2023）
・アジア太平洋のアログリプチン安息香酸塩錠の種類別販売量
・アジア太平洋のアログリプチン安息香酸塩錠の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアログリプチン安息香酸塩錠販売量、売上（2018-2023）
・ヨーロッパのアログリプチン安息香酸塩錠の種類別販売量
・ヨーロッパのアログリプチン安息香酸塩錠の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアログリプチン安息香酸塩錠販売量、売上（2018-2023）
・中東・アフリカのアログリプチン安息香酸塩錠の種類別販売量
・中東・アフリカのアログリプチン安息香酸塩錠の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アログリプチン安息香酸塩錠の製造コスト構造分析
・アログリプチン安息香酸塩錠の製造プロセス分析
・アログリプチン安息香酸塩錠の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アログリプチン安息香酸塩錠の主要なグローバル販売業者
・アログリプチン安息香酸塩錠の主要なグローバル顧客

地域別のアログリプチン安息香酸塩錠市場予測レビュー
・地域別のアログリプチン安息香酸塩錠市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アログリプチン安息香酸塩錠の種類別市場規模予測
・アログリプチン安息香酸塩錠の用途別市場規模予測

主要企業分析
Takeda Pharmaceutical、 Perrigo、 Navana Pharmaceuticals、 China National Medicines Guorui Pharmaceutical、 Reyoung Pharmaceutical、 Yichang HEC ChangJiang Pharmaceutical、 Chongqing Kerui Nanhai Pharmaceutical、 Yabao Pharmaceutical、 Zhejiang Huabett Pharmaceutical、 Sunshine Lake Pharma、 Jiangsu Deyuan Pharmaceutical、 Qianjin Xiangjiang Pharmageuical、 CSPC Ouyi Pharmaceutical、 Shenzhen Haibin Pharmaceutical
・企業情報
・アログリプチン安息香酸塩錠製品
・アログリプチン安息香酸塩錠販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Alogliptin Benzoate Tablet market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Alogliptin Benzoate Tablet is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Alogliptin Benzoate Tablet is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Alogliptin Benzoate Tablet is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Alogliptin Benzoate Tablet players cover Takeda Pharmaceutical, Perrigo, Navana Pharmaceuticals, China National Medicines Guorui Pharmaceutical, Reyoung Pharmaceutical, Yichang HEC ChangJiang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Yabao Pharmaceutical and Zhejiang Huabett Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Alogliptin Benzoate Tablet, this product is suitable for the treatment of type 2 diabetes mellitus. 1) Monotherapy This product is used as an adjunct therapy for diet control and exercise to improve blood glucose control in patients with type 2 diabetes mellitus. 2) Combined with metformin hydrochloride When metformin hydrochloride alone cannot effectively control blood glucose, this product can be used in combination with metformin hydrochloride to improve blood glucose control in patients with type 2 diabetes on the basis of diet and exercise. 3) Important Limitations of use This product is not intended for use in patients with type 1 diabetes or diabetic ketoacidosis as its effectiveness has not been determined.
LPI (LP Information)’ newest research report, the “Alogliptin Benzoate Tablet Industry Forecast” looks at past sales and reviews total world Alogliptin Benzoate Tablet sales in 2022, providing a comprehensive analysis by region and market sector of projected Alogliptin Benzoate Tablet sales for 2023 through 2029. With Alogliptin Benzoate Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alogliptin Benzoate Tablet industry.
This Insight Report provides a comprehensive analysis of the global Alogliptin Benzoate Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alogliptin Benzoate Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alogliptin Benzoate Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alogliptin Benzoate Tablet and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alogliptin Benzoate Tablet.
This report presents a comprehensive overview, market shares, and growth opportunities of Alogliptin Benzoate Tablet market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
6.25mg/Tablet
12.5mg/Tablet
25mg/Tablet
Segmentation by application
Hospital
Clinic
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Takeda Pharmaceutical
Perrigo
Navana Pharmaceuticals
China National Medicines Guorui Pharmaceutical
Reyoung Pharmaceutical
Yichang HEC ChangJiang Pharmaceutical
Chongqing Kerui Nanhai Pharmaceutical
Yabao Pharmaceutical
Zhejiang Huabett Pharmaceutical
Sunshine Lake Pharma
Jiangsu Deyuan Pharmaceutical
Qianjin Xiangjiang Pharmageuical
CSPC Ouyi Pharmaceutical
Shenzhen Haibin Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alogliptin Benzoate Tablet market?
What factors are driving Alogliptin Benzoate Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alogliptin Benzoate Tablet market opportunities vary by end market size?
How does Alogliptin Benzoate Tablet break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alogliptin Benzoate Tablet Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Alogliptin Benzoate Tablet by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Alogliptin Benzoate Tablet by Country/Region, 2018, 2022 & 2029
2.2 Alogliptin Benzoate Tablet Segment by Type
2.2.1 6.25mg/Tablet
2.2.2 12.5mg/Tablet
2.2.3 25mg/Tablet
2.3 Alogliptin Benzoate Tablet Sales by Type
2.3.1 Global Alogliptin Benzoate Tablet Sales Market Share by Type (2018-2023)
2.3.2 Global Alogliptin Benzoate Tablet Revenue and Market Share by Type (2018-2023)
2.3.3 Global Alogliptin Benzoate Tablet Sale Price by Type (2018-2023)
2.4 Alogliptin Benzoate Tablet Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Alogliptin Benzoate Tablet Sales by Application
2.5.1 Global Alogliptin Benzoate Tablet Sale Market Share by Application (2018-2023)
2.5.2 Global Alogliptin Benzoate Tablet Revenue and Market Share by Application (2018-2023)
2.5.3 Global Alogliptin Benzoate Tablet Sale Price by Application (2018-2023)
3 Global Alogliptin Benzoate Tablet by Company
3.1 Global Alogliptin Benzoate Tablet Breakdown Data by Company
3.1.1 Global Alogliptin Benzoate Tablet Annual Sales by Company (2018-2023)
3.1.2 Global Alogliptin Benzoate Tablet Sales Market Share by Company (2018-2023)
3.2 Global Alogliptin Benzoate Tablet Annual Revenue by Company (2018-2023)
3.2.1 Global Alogliptin Benzoate Tablet Revenue by Company (2018-2023)
3.2.2 Global Alogliptin Benzoate Tablet Revenue Market Share by Company (2018-2023)
3.3 Global Alogliptin Benzoate Tablet Sale Price by Company
3.4 Key Manufacturers Alogliptin Benzoate Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alogliptin Benzoate Tablet Product Location Distribution
3.4.2 Players Alogliptin Benzoate Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alogliptin Benzoate Tablet by Geographic Region
4.1 World Historic Alogliptin Benzoate Tablet Market Size by Geographic Region (2018-2023)
4.1.1 Global Alogliptin Benzoate Tablet Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Alogliptin Benzoate Tablet Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Alogliptin Benzoate Tablet Market Size by Country/Region (2018-2023)
4.2.1 Global Alogliptin Benzoate Tablet Annual Sales by Country/Region (2018-2023)
4.2.2 Global Alogliptin Benzoate Tablet Annual Revenue by Country/Region (2018-2023)
4.3 Americas Alogliptin Benzoate Tablet Sales Growth
4.4 APAC Alogliptin Benzoate Tablet Sales Growth
4.5 Europe Alogliptin Benzoate Tablet Sales Growth
4.6 Middle East & Africa Alogliptin Benzoate Tablet Sales Growth
5 Americas
5.1 Americas Alogliptin Benzoate Tablet Sales by Country
5.1.1 Americas Alogliptin Benzoate Tablet Sales by Country (2018-2023)
5.1.2 Americas Alogliptin Benzoate Tablet Revenue by Country (2018-2023)
5.2 Americas Alogliptin Benzoate Tablet Sales by Type
5.3 Americas Alogliptin Benzoate Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alogliptin Benzoate Tablet Sales by Region
6.1.1 APAC Alogliptin Benzoate Tablet Sales by Region (2018-2023)
6.1.2 APAC Alogliptin Benzoate Tablet Revenue by Region (2018-2023)
6.2 APAC Alogliptin Benzoate Tablet Sales by Type
6.3 APAC Alogliptin Benzoate Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alogliptin Benzoate Tablet by Country
7.1.1 Europe Alogliptin Benzoate Tablet Sales by Country (2018-2023)
7.1.2 Europe Alogliptin Benzoate Tablet Revenue by Country (2018-2023)
7.2 Europe Alogliptin Benzoate Tablet Sales by Type
7.3 Europe Alogliptin Benzoate Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alogliptin Benzoate Tablet by Country
8.1.1 Middle East & Africa Alogliptin Benzoate Tablet Sales by Country (2018-2023)
8.1.2 Middle East & Africa Alogliptin Benzoate Tablet Revenue by Country (2018-2023)
8.2 Middle East & Africa Alogliptin Benzoate Tablet Sales by Type
8.3 Middle East & Africa Alogliptin Benzoate Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alogliptin Benzoate Tablet
10.3 Manufacturing Process Analysis of Alogliptin Benzoate Tablet
10.4 Industry Chain Structure of Alogliptin Benzoate Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alogliptin Benzoate Tablet Distributors
11.3 Alogliptin Benzoate Tablet Customer
12 World Forecast Review for Alogliptin Benzoate Tablet by Geographic Region
12.1 Global Alogliptin Benzoate Tablet Market Size Forecast by Region
12.1.1 Global Alogliptin Benzoate Tablet Forecast by Region (2024-2029)
12.1.2 Global Alogliptin Benzoate Tablet Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alogliptin Benzoate Tablet Forecast by Type
12.7 Global Alogliptin Benzoate Tablet Forecast by Application
13 Key Players Analysis
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Perrigo
13.2.1 Perrigo Company Information
13.2.2 Perrigo Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.2.3 Perrigo Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Perrigo Main Business Overview
13.2.5 Perrigo Latest Developments
13.3 Navana Pharmaceuticals
13.3.1 Navana Pharmaceuticals Company Information
13.3.2 Navana Pharmaceuticals Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.3.3 Navana Pharmaceuticals Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Navana Pharmaceuticals Main Business Overview
13.3.5 Navana Pharmaceuticals Latest Developments
13.4 China National Medicines Guorui Pharmaceutical
13.4.1 China National Medicines Guorui Pharmaceutical Company Information
13.4.2 China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.4.3 China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 China National Medicines Guorui Pharmaceutical Main Business Overview
13.4.5 China National Medicines Guorui Pharmaceutical Latest Developments
13.5 Reyoung Pharmaceutical
13.5.1 Reyoung Pharmaceutical Company Information
13.5.2 Reyoung Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.5.3 Reyoung Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Reyoung Pharmaceutical Main Business Overview
13.5.5 Reyoung Pharmaceutical Latest Developments
13.6 Yichang HEC ChangJiang Pharmaceutical
13.6.1 Yichang HEC ChangJiang Pharmaceutical Company Information
13.6.2 Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.6.3 Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yichang HEC ChangJiang Pharmaceutical Main Business Overview
13.6.5 Yichang HEC ChangJiang Pharmaceutical Latest Developments
13.7 Chongqing Kerui Nanhai Pharmaceutical
13.7.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
13.7.2 Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.7.3 Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chongqing Kerui Nanhai Pharmaceutical Main Business Overview
13.7.5 Chongqing Kerui Nanhai Pharmaceutical Latest Developments
13.8 Yabao Pharmaceutical
13.8.1 Yabao Pharmaceutical Company Information
13.8.2 Yabao Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.8.3 Yabao Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yabao Pharmaceutical Main Business Overview
13.8.5 Yabao Pharmaceutical Latest Developments
13.9 Zhejiang Huabett Pharmaceutical
13.9.1 Zhejiang Huabett Pharmaceutical Company Information
13.9.2 Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.9.3 Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zhejiang Huabett Pharmaceutical Main Business Overview
13.9.5 Zhejiang Huabett Pharmaceutical Latest Developments
13.10 Sunshine Lake Pharma
13.10.1 Sunshine Lake Pharma Company Information
13.10.2 Sunshine Lake Pharma Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.10.3 Sunshine Lake Pharma Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sunshine Lake Pharma Main Business Overview
13.10.5 Sunshine Lake Pharma Latest Developments
13.11 Jiangsu Deyuan Pharmaceutical
13.11.1 Jiangsu Deyuan Pharmaceutical Company Information
13.11.2 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.11.3 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Deyuan Pharmaceutical Main Business Overview
13.11.5 Jiangsu Deyuan Pharmaceutical Latest Developments
13.12 Qianjin Xiangjiang Pharmageuical
13.12.1 Qianjin Xiangjiang Pharmageuical Company Information
13.12.2 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.12.3 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Qianjin Xiangjiang Pharmageuical Main Business Overview
13.12.5 Qianjin Xiangjiang Pharmageuical Latest Developments
13.13 CSPC Ouyi Pharmaceutical
13.13.1 CSPC Ouyi Pharmaceutical Company Information
13.13.2 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.13.3 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 CSPC Ouyi Pharmaceutical Main Business Overview
13.13.5 CSPC Ouyi Pharmaceutical Latest Developments
13.14 Shenzhen Haibin Pharmaceutical
13.14.1 Shenzhen Haibin Pharmaceutical Company Information
13.14.2 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
13.14.3 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shenzhen Haibin Pharmaceutical Main Business Overview
13.14.5 Shenzhen Haibin Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Alogliptin Benzoate Tablet Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Alogliptin Benzoate Tablet Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 6.25mg/Tablet
Table 4. Major Players of 12.5mg/Tablet
Table 5. Major Players of 25mg/Tablet
Table 6. Global Alogliptin Benzoate Tablet Sales by Type (2018-2023) & (K Units)
Table 7. Global Alogliptin Benzoate Tablet Sales Market Share by Type (2018-2023)
Table 8. Global Alogliptin Benzoate Tablet Revenue by Type (2018-2023) & ($ million)
Table 9. Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2018-2023)
Table 10. Global Alogliptin Benzoate Tablet Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Alogliptin Benzoate Tablet Sales by Application (2018-2023) & (K Units)
Table 12. Global Alogliptin Benzoate Tablet Sales Market Share by Application (2018-2023)
Table 13. Global Alogliptin Benzoate Tablet Revenue by Application (2018-2023)
Table 14. Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2018-2023)
Table 15. Global Alogliptin Benzoate Tablet Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Alogliptin Benzoate Tablet Sales by Company (2018-2023) & (K Units)
Table 17. Global Alogliptin Benzoate Tablet Sales Market Share by Company (2018-2023)
Table 18. Global Alogliptin Benzoate Tablet Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Alogliptin Benzoate Tablet Revenue Market Share by Company (2018-2023)
Table 20. Global Alogliptin Benzoate Tablet Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Alogliptin Benzoate Tablet Producing Area Distribution and Sales Area
Table 22. Players Alogliptin Benzoate Tablet Products Offered
Table 23. Alogliptin Benzoate Tablet Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Alogliptin Benzoate Tablet Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Alogliptin Benzoate Tablet Sales Market Share Geographic Region (2018-2023)
Table 28. Global Alogliptin Benzoate Tablet Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Alogliptin Benzoate Tablet Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Alogliptin Benzoate Tablet Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Alogliptin Benzoate Tablet Sales Market Share by Country/Region (2018-2023)
Table 32. Global Alogliptin Benzoate Tablet Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Alogliptin Benzoate Tablet Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Alogliptin Benzoate Tablet Sales by Country (2018-2023) & (K Units)
Table 35. Americas Alogliptin Benzoate Tablet Sales Market Share by Country (2018-2023)
Table 36. Americas Alogliptin Benzoate Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Alogliptin Benzoate Tablet Revenue Market Share by Country (2018-2023)
Table 38. Americas Alogliptin Benzoate Tablet Sales by Type (2018-2023) & (K Units)
Table 39. Americas Alogliptin Benzoate Tablet Sales by Application (2018-2023) & (K Units)
Table 40. APAC Alogliptin Benzoate Tablet Sales by Region (2018-2023) & (K Units)
Table 41. APAC Alogliptin Benzoate Tablet Sales Market Share by Region (2018-2023)
Table 42. APAC Alogliptin Benzoate Tablet Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Alogliptin Benzoate Tablet Revenue Market Share by Region (2018-2023)
Table 44. APAC Alogliptin Benzoate Tablet Sales by Type (2018-2023) & (K Units)
Table 45. APAC Alogliptin Benzoate Tablet Sales by Application (2018-2023) & (K Units)
Table 46. Europe Alogliptin Benzoate Tablet Sales by Country (2018-2023) & (K Units)
Table 47. Europe Alogliptin Benzoate Tablet Sales Market Share by Country (2018-2023)
Table 48. Europe Alogliptin Benzoate Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Alogliptin Benzoate Tablet Revenue Market Share by Country (2018-2023)
Table 50. Europe Alogliptin Benzoate Tablet Sales by Type (2018-2023) & (K Units)
Table 51. Europe Alogliptin Benzoate Tablet Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Alogliptin Benzoate Tablet Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Alogliptin Benzoate Tablet Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Alogliptin Benzoate Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Alogliptin Benzoate Tablet Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Alogliptin Benzoate Tablet Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Alogliptin Benzoate Tablet Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Alogliptin Benzoate Tablet
Table 59. Key Market Challenges & Risks of Alogliptin Benzoate Tablet
Table 60. Key Industry Trends of Alogliptin Benzoate Tablet
Table 61. Alogliptin Benzoate Tablet Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Alogliptin Benzoate Tablet Distributors List
Table 64. Alogliptin Benzoate Tablet Customer List
Table 65. Global Alogliptin Benzoate Tablet Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Alogliptin Benzoate Tablet Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Alogliptin Benzoate Tablet Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Alogliptin Benzoate Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Alogliptin Benzoate Tablet Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Alogliptin Benzoate Tablet Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Alogliptin Benzoate Tablet Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Alogliptin Benzoate Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Alogliptin Benzoate Tablet Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Alogliptin Benzoate Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Alogliptin Benzoate Tablet Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Alogliptin Benzoate Tablet Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Alogliptin Benzoate Tablet Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Alogliptin Benzoate Tablet Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Takeda Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 81. Takeda Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Takeda Pharmaceutical Main Business
Table 83. Takeda Pharmaceutical Latest Developments
Table 84. Perrigo Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 85. Perrigo Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 86. Perrigo Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Perrigo Main Business
Table 88. Perrigo Latest Developments
Table 89. Navana Pharmaceuticals Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 90. Navana Pharmaceuticals Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 91. Navana Pharmaceuticals Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Navana Pharmaceuticals Main Business
Table 93. Navana Pharmaceuticals Latest Developments
Table 94. China National Medicines Guorui Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 95. China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 96. China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. China National Medicines Guorui Pharmaceutical Main Business
Table 98. China National Medicines Guorui Pharmaceutical Latest Developments
Table 99. Reyoung Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 100. Reyoung Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 101. Reyoung Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Reyoung Pharmaceutical Main Business
Table 103. Reyoung Pharmaceutical Latest Developments
Table 104. Yichang HEC ChangJiang Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 105. Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 106. Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Yichang HEC ChangJiang Pharmaceutical Main Business
Table 108. Yichang HEC ChangJiang Pharmaceutical Latest Developments
Table 109. Chongqing Kerui Nanhai Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 110. Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 111. Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Chongqing Kerui Nanhai Pharmaceutical Main Business
Table 113. Chongqing Kerui Nanhai Pharmaceutical Latest Developments
Table 114. Yabao Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 115. Yabao Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 116. Yabao Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Yabao Pharmaceutical Main Business
Table 118. Yabao Pharmaceutical Latest Developments
Table 119. Zhejiang Huabett Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 120. Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 121. Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Zhejiang Huabett Pharmaceutical Main Business
Table 123. Zhejiang Huabett Pharmaceutical Latest Developments
Table 124. Sunshine Lake Pharma Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 125. Sunshine Lake Pharma Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 126. Sunshine Lake Pharma Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Sunshine Lake Pharma Main Business
Table 128. Sunshine Lake Pharma Latest Developments
Table 129. Jiangsu Deyuan Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 130. Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 131. Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Jiangsu Deyuan Pharmaceutical Main Business
Table 133. Jiangsu Deyuan Pharmaceutical Latest Developments
Table 134. Qianjin Xiangjiang Pharmageuical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 135. Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 136. Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Qianjin Xiangjiang Pharmageuical Main Business
Table 138. Qianjin Xiangjiang Pharmageuical Latest Developments
Table 139. CSPC Ouyi Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 140. CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 141. CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. CSPC Ouyi Pharmaceutical Main Business
Table 143. CSPC Ouyi Pharmaceutical Latest Developments
Table 144. Shenzhen Haibin Pharmaceutical Basic Information, Alogliptin Benzoate Tablet Manufacturing Base, Sales Area and Its Competitors
Table 145. Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Product Portfolios and Specifications
Table 146. Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Shenzhen Haibin Pharmaceutical Main Business
Table 148. Shenzhen Haibin Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Alogliptin Benzoate Tablet
Figure 2. Alogliptin Benzoate Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alogliptin Benzoate Tablet Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Alogliptin Benzoate Tablet Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Alogliptin Benzoate Tablet Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 6.25mg/Tablet
Figure 10. Product Picture of 12.5mg/Tablet
Figure 11. Product Picture of 25mg/Tablet
Figure 12. Global Alogliptin Benzoate Tablet Sales Market Share by Type in 2022
Figure 13. Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2018-2023)
Figure 14. Alogliptin Benzoate Tablet Consumed in Hospital
Figure 15. Global Alogliptin Benzoate Tablet Market: Hospital (2018-2023) & (K Units)
Figure 16. Alogliptin Benzoate Tablet Consumed in Clinic
Figure 17. Global Alogliptin Benzoate Tablet Market: Clinic (2018-2023) & (K Units)
Figure 18. Alogliptin Benzoate Tablet Consumed in Pharmacy
Figure 19. Global Alogliptin Benzoate Tablet Market: Pharmacy (2018-2023) & (K Units)
Figure 20. Global Alogliptin Benzoate Tablet Sales Market Share by Application (2022)
Figure 21. Global Alogliptin Benzoate Tablet Revenue Market Share by Application in 2022
Figure 22. Alogliptin Benzoate Tablet Sales Market by Company in 2022 (K Units)
Figure 23. Global Alogliptin Benzoate Tablet Sales Market Share by Company in 2022
Figure 24. Alogliptin Benzoate Tablet Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Alogliptin Benzoate Tablet Revenue Market Share by Company in 2022
Figure 26. Global Alogliptin Benzoate Tablet Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Alogliptin Benzoate Tablet Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Alogliptin Benzoate Tablet Sales 2018-2023 (K Units)
Figure 29. Americas Alogliptin Benzoate Tablet Revenue 2018-2023 ($ Millions)
Figure 30. APAC Alogliptin Benzoate Tablet Sales 2018-2023 (K Units)
Figure 31. APAC Alogliptin Benzoate Tablet Revenue 2018-2023 ($ Millions)
Figure 32. Europe Alogliptin Benzoate Tablet Sales 2018-2023 (K Units)
Figure 33. Europe Alogliptin Benzoate Tablet Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Alogliptin Benzoate Tablet Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Alogliptin Benzoate Tablet Revenue 2018-2023 ($ Millions)
Figure 36. Americas Alogliptin Benzoate Tablet Sales Market Share by Country in 2022
Figure 37. Americas Alogliptin Benzoate Tablet Revenue Market Share by Country in 2022
Figure 38. Americas Alogliptin Benzoate Tablet Sales Market Share by Type (2018-2023)
Figure 39. Americas Alogliptin Benzoate Tablet Sales Market Share by Application (2018-2023)
Figure 40. United States Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Alogliptin Benzoate Tablet Sales Market Share by Region in 2022
Figure 45. APAC Alogliptin Benzoate Tablet Revenue Market Share by Regions in 2022
Figure 46. APAC Alogliptin Benzoate Tablet Sales Market Share by Type (2018-2023)
Figure 47. APAC Alogliptin Benzoate Tablet Sales Market Share by Application (2018-2023)
Figure 48. China Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Alogliptin Benzoate Tablet Sales Market Share by Country in 2022
Figure 56. Europe Alogliptin Benzoate Tablet Revenue Market Share by Country in 2022
Figure 57. Europe Alogliptin Benzoate Tablet Sales Market Share by Type (2018-2023)
Figure 58. Europe Alogliptin Benzoate Tablet Sales Market Share by Application (2018-2023)
Figure 59. Germany Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Alogliptin Benzoate Tablet Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Alogliptin Benzoate Tablet Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Alogliptin Benzoate Tablet Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Alogliptin Benzoate Tablet Sales Market Share by Application (2018-2023)
Figure 68. Egypt Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Alogliptin Benzoate Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Alogliptin Benzoate Tablet in 2022
Figure 74. Manufacturing Process Analysis of Alogliptin Benzoate Tablet
Figure 75. Industry Chain Structure of Alogliptin Benzoate Tablet
Figure 76. Channels of Distribution
Figure 77. Global Alogliptin Benzoate Tablet Sales Market Forecast by Region (2024-2029)
Figure 78. Global Alogliptin Benzoate Tablet Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Alogliptin Benzoate Tablet Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Alogliptin Benzoate Tablet Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Alogliptin Benzoate Tablet Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Alogliptin Benzoate Tablet Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアログリプチン安息香酸塩錠市場予測 2023年-2029年] (コード：LP23DC05240)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアログリプチン安息香酸塩錠市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の製薬産業用回転式打錠機市場予測 2023年-2029年
  • 世界のアセチルスピラマイシン錠市場予測 2023年-2029年
  • 世界のタブレット端末向けDDIC市場予測 2023年-2029年
  • 世界のオランザピン錠市場予測 2023年-2029年
  • 世界のベンダゾール錠市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆